Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Man-Hon Wong

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Genome Medicine|March 3, 2025
STModule: identifying tissue modules to uncover spatial components and characteristics of transcriptomic landscapesRan Wang, Yan Qian, Xiaojing Guo, et al.
Plos Computational Biology|October 21, 2024
scCaT: An explainable capsulating architecture for sepsis diagnosis transferring from single-cell RNA sequencingXubin Zheng, Dian Meng, Duo Chen, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 22, 2014
Highly sensitive gas sensor by the LaAlO3 /SrTiO3 heterostructure with Pd nanoparticle surface modulationNgai Yui Chan, Meng Zhao, JianXing Huang, et al.
Chemical Biology & Drug Design|September 25, 2016
In silico prediction and in vitro and in vivo validation of acaricide fluazuron as a potential inhibitor of FGFR3 and a candidate anticancer drug for bladder carcinomaKunbin Ke, Hongjian Li, Hong Yao, et al.
Frontiers in Pharmacology|November 5, 2016
Rapid HPLC Quantification Approach for Detection of Active Constituents in Modern Combinatorial Formula, San-Huang-Xie-Xin-Tang (SHXXT)Tung-Ying Wu, Fang-Rong Chang, Jing-Ru Liou, et al.
Scientific Reports|December 23, 2017
Econazole nitrate inhibits PI3K activity and promotes apoptosis in lung cancer cellsChao Dong, Runxiang Yang, Hongjian Li, et al.
Oncology Reports|June 30, 2018
Discovery of rafoxanide as a dual CDK4/6 inhibitor for the treatment of skin cancerXinan Shi, Hongjian Li, Anhua Shi, et al.
Molecular Medicine (Cambridge, Mass.)|February 13, 2021
Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinomaYing Zhu, Kun-Bin Ke, Zhong-Kun Xia, et al.
Frontiers in Pharmacology|August 2, 2021
Discovery of a New CDK4/6 and PI3K/AKT Multiple Kinase Inhibitor Aminoquinol for the Treatment of Hepatocellular CarcinomaZhong-Kun Xia, Wei Wang, Jian-Ge Qiu, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Genome Medicine|March 3, 2025
STModule: identifying tissue modules to uncover spatial components and characteristics of transcriptomic landscapesRan Wang, Yan Qian, Xiaojing Guo, et al.
Plos Computational Biology|October 21, 2024
scCaT: An explainable capsulating architecture for sepsis diagnosis transferring from single-cell RNA sequencingXubin Zheng, Dian Meng, Duo Chen, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 22, 2014
Highly sensitive gas sensor by the LaAlO3 /SrTiO3 heterostructure with Pd nanoparticle surface modulationNgai Yui Chan, Meng Zhao, JianXing Huang, et al.
Chemical Biology & Drug Design|September 25, 2016
In silico prediction and in vitro and in vivo validation of acaricide fluazuron as a potential inhibitor of FGFR3 and a candidate anticancer drug for bladder carcinomaKunbin Ke, Hongjian Li, Hong Yao, et al.
Frontiers in Pharmacology|November 5, 2016
Rapid HPLC Quantification Approach for Detection of Active Constituents in Modern Combinatorial Formula, San-Huang-Xie-Xin-Tang (SHXXT)Tung-Ying Wu, Fang-Rong Chang, Jing-Ru Liou, et al.
Scientific Reports|December 23, 2017
Econazole nitrate inhibits PI3K activity and promotes apoptosis in lung cancer cellsChao Dong, Runxiang Yang, Hongjian Li, et al.
Oncology Reports|June 30, 2018
Discovery of rafoxanide as a dual CDK4/6 inhibitor for the treatment of skin cancerXinan Shi, Hongjian Li, Anhua Shi, et al.
Molecular Medicine (Cambridge, Mass.)|February 13, 2021
Discovery of vanoxerine dihydrochloride as a CDK2/4/6 triple-inhibitor for the treatment of human hepatocellular carcinomaYing Zhu, Kun-Bin Ke, Zhong-Kun Xia, et al.
Frontiers in Pharmacology|August 2, 2021
Discovery of a New CDK4/6 and PI3K/AKT Multiple Kinase Inhibitor Aminoquinol for the Treatment of Hepatocellular CarcinomaZhong-Kun Xia, Wei Wang, Jian-Ge Qiu, et al.
Pageof 4